Overview

Veterinary Biologics Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027.

Biologics drugs are used for boosting the immune system to defend the body against infections. Veterinary biologics products are derived from biological processes and living organisms. They are used for preventing, treating or diagnosing animal function and diseases using an immunological procedure. Rising occurrence of chronic animal diseases, increased emphasis of key players in R&D of novel veterinary biological products in combating newly emerged animal diseases are predicted to boost the veterinary biologics market growth. Furthermore, growing investments made by government organizations and increased insistence for meat, milk, fish and eggs are some other factors responsible for the proliferation of the market. Moreover, technological advancement in veterinary biologics like immunomodulators and monoclonal antibodies shall boost the market growth. For instance, Zoetis’s Cytopoint, which is the first of its kind monoclonal antibody for veterinary use by EU.

Veterinary Biologics Market

Market Segmentation:

By Product
•    Diagnostic Kits
•    Vaccines
•    Antiserums and Antibodies
•    Immunomodulators
•    Others     
By Animal Type 
•    Companion Animals
•    Livestock Animals    
By Disease Type
•    Foot & Mouth Disease
•    Tuberculosis and Brucellosis
•    Bluetongue
•    Others
By Distribution Channel
•    Veterinary Clinics
•    Veterinary Hospitals 
•    Others
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is categorised into product, animal type, disease type, distribution channel and region. The product segment is diversified into diagnostic kits, vaccines, antiserums and antibodies, immunomodulators and others. The vaccines segment is predicted to hold the largest veterinary biologics market share owing to technological advancements in vaccine development along with consistent resistance of drugs by pathogens. Furthermore, the development of veterinary vaccines has preclinical trial requirements and non-stringent regulations. Thus, emerging market players have the opportunity of entering the market with advanced product developments. The animal type segment is classified into companion animals and livestock animals. Veterinary biologics are mainly used on livestock animals which is the reason this segment is predicted to lead the market during the forecast period. The disease type segment is fragmented into foot & mouth disease, tuberculosis and brucellosis, bluetongue and others. The distribution channel segment is diversified into veterinary clinics, veterinary hospitals and others. The veterinary hospitals segment is predicted to lead the market owing to bolstering governmental support along with the provision of all veterinary treatments.

Regional Analysis:

The North America region subjugated the market due to rising issues regarding pet healthcare and high product costs. Favourable support from the government for developing novel biologic drugs is predicted to boost the market in the European region. The Biotechnology and Biological Sciences Research Council, in December 2015, funded over 5 million GBP for developing poultry vaccines to the London School of Tropical Medicine and Hygiene. Mandates in government necessities for animal immunization, increasing demand for zoonotic and rising ownership of companion animals are some of the veterinary biologics market trends in the Asia Pacific region.

Competitive Landscape:                            

Some of the key market players associated are Zoetis Inc., Merck Animal Health, Boehringer Ingelheim GmbH, Bayer AG, Eli Lilly & Company, Abaxis, OMEGA, Hebei Veyong Animal Pharmaceutical Co. Ltd.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global veterinary biologics market by product, by animal type, by disease type, by distribution channel and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics